89 related articles for article (PubMed ID: 13677614)
21. Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.
Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
Am J Hematol; 2001 May; 67(1):20-6. PubMed ID: 11279653
[TBL] [Abstract][Full Text] [Related]
22. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-1 signals independently of beta1 integrins during Raji cell spreading.
Lebakken CS; McQuade KJ; Rapraeger AC
Exp Cell Res; 2000 Sep; 259(2):315-25. PubMed ID: 10964499
[TBL] [Abstract][Full Text] [Related]
24. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
25. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
26. Expression of proteoglycan core proteins in human bone marrow stroma.
Schofield KP; Gallagher JT; David G
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
[TBL] [Abstract][Full Text] [Related]
28. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan.
Sanderson RD; Sneed TB; Young LA; Sullivan GL; Lander AD
J Immunol; 1992 Jun; 148(12):3902-11. PubMed ID: 1602136
[TBL] [Abstract][Full Text] [Related]
29. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
30. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
Bakker AB; van den Oudenrijn S; Bakker AQ; Feller N; van Meijer M; Bia JA; Jongeneelen MA; Visser TJ; Bijl N; Geuijen CA; Marissen WE; Radosevic K; Throsby M; Schuurhuis GJ; Ossenkoppele GJ; de Kruif J; Goudsmit J; Kruisbeek AM
Cancer Res; 2004 Nov; 64(22):8443-50. PubMed ID: 15548716
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
32. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
33. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.
Charnaux N; Brule S; Chaigneau T; Saffar L; Sutton A; Hamon M; Prost C; Lievre N; Vita C; Gattegno L
Glycobiology; 2005 Feb; 15(2):119-30. PubMed ID: 15355933
[TBL] [Abstract][Full Text] [Related]
34. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
35. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium.
Gulyás M; Hjerpe A
J Pathol; 2003 Apr; 199(4):479-87. PubMed ID: 12635139
[TBL] [Abstract][Full Text] [Related]
36. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
[TBL] [Abstract][Full Text] [Related]
37. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
38. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
39. [Is syndecan-1 an independent prognostic factor in patients with laryngeal carcinoma?].
Klatka J; Skomra D; Paduch R; Kupisz K; Tryka E; Harytanowicz M; Kłos A
Otolaryngol Pol; 2004; 58(5):933-40. PubMed ID: 15732779
[TBL] [Abstract][Full Text] [Related]
40. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.
Wijdenes J; Vooijs WC; Clément C; Post J; Morard F; Vita N; Laurent P; Sun RX; Klein B; Dore JM
Br J Haematol; 1996 Aug; 94(2):318-23. PubMed ID: 8759892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
